Journals / Glokom Katarakt / 2013 / Cilt: 8 - Sayı: 3

Cortical cataract formation and treatment in a young keratoconus patient after collagen cross linking treatment

Kollajen çapraz bağlama tedavisi yapılan genç kertokonus hastasında kortikal katarakt gelişimi ve tedavisi

Pages
194–198
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present a case of significant cataract formation in a young keratoconus patient after collagen crosslink- ing procedure, necessitating phacoemulsification with a posterior chamber implant.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Keratoconus is a progressive, noninflammatory, bilateral ectatic corneal disease.
📊
Key Findings & Data:The interaction of riboflavin and UVA (365 nm) causes the formation of reactive oxygen species which creates chemical bonds (crosslinks) between collagen molecules.
💡
Conclusion & Impact:We present a case of significant cataract formation in a young keratoconus patient after collagen crosslink- ing procedure, necessitating phacoemulsification with a posterior chamber implant.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Keratoconus is a progressive, noninflammatory, bilateral ectatic corneal disease. Visual impairment occurs as a result of irregular astigmatism, progressive myopia, and secondary corneal scarring. Collagen crosslinking by riboflavin and ultra- violet-A (UVA) stabilizes progressive keratoconus by addressing some of the underlying pathophysiological mechanisms of the disease. The interaction of riboflavin and UVA (365 nm) causes the formation of reactive oxygen species which creates chemical bonds (crosslinks) between collagen molecules. Oxidative damage effect of UVA exposure is potential complication of this procedure. We present a case of significant cataract formation in a young keratoconus patient after collagen crosslink- ing procedure, necessitating phacoemulsification with a posterior chamber implant.

Özet

Keratokonus ilerleyici, enflamatuar olmayan, bilateral ektatik bir kornea hastalığıdır. Görme bozukluğu, düzensiz astig- matizma, ilerleyici miyopi, ve ikincil kornea skarlasması hastalığın ilerleyen dönemlerinde bir sonuç olarak ortaya çıkar. Riboflavin ve ultraviyole A (UVA) tarafından gerçekleşen Kollajen çapraz bağlama tedavisi hastalığın altında yatan bazı progresif patofizyolojik mekanizmaları stabilize eder. Riboflavin ve UVA (365 nm) etkileşimi ile reaktif oksijen türleri ve sonuç olarak kollajen molekülleri arasında kimyasal bağlar(çapraz bağlar) oluşumuna neden olur. UVA ve reaktif oksijen radikallerinin varlığı bu prosedürün potansiyel komplikasyonudur. Bu çalışmada genç bir keratokonus hastasında kollajen çapraz bağlama işlemi sonrası fakoemülsifikasyon ve arka kamara lensi implantasyonu gerektiren bir katarakt olgusu sunulmuştur.

🔖

Cite This Article

ÖZÇELİK, F., ÇELİK, U., BAŞARIR, B., AĞCA, A., ÖZKAYA, A., DEMİROK, A. (2013). Cortical cataract formation and treatment in a young keratoconus patient after collagen cross linking treatment. Glokom Katarakt, Cilt: 8 - Sayı: 3, 194–198. https://ajindex.com/articles/212495

References (15)

  1. Wollensak. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006;17:356-60
  2. Wollensak G, Spoerl E, Seiler T. Stress-strain measure- ments of human and porcine corneas after riboflavin-ul- traviolet- A-induced cross-linking. J Cataract Refract Surg 2003;29:1780-5
  3. Vinciguerra P., Albe E., Mahmoud A. M., et al. Intra-and post- operative variation in ocular response analyzer parameters in keratoconic eyes after corneal cross-linking. Journal of Re- fractive Surgery 2010;26: 669-76
  4. Wollensak, E. Spoerl, M. Wilsch, et al. Endothelial cell dam- age after riboflavin-ultraviolet-A treatment in the rabbit. Journal of Cataract and Refractive Surgery 2003;29;1786-90
  5. Wollensak G. Crosslinking treatment of progressive keratoco- nus: new hope. Curr Opin Ophthalmol 2006;17:356-60
  6. Pollhammer and C. Cursiefen. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. Journal of Cataract and Refractive Surgery 2009;35:588-589
  7. Kymionis, D. M. Portaliou, D. I. Bouzoukis et al. Herpetic ker- atitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. Journal of Cataract and Refrac- tive Surgery 2007;33:1982-4
  8. Raiskup, A. Hoyer, and E. Spoerl. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. Journal of Refractive Surgery 2009;25:824-8
  9. Koller T., Mrochen M., Seiler T. Complication and failure rates after corneal crosslinking. Journal of Cataract and Re- fractive Surgery 2009;35:1358-62
  10. Angunawela R. I., Arnalich-Montiel F., Allan B.D.S. Peripher- al sterile corneal infiltrates and melting after collagen cross- linking for keratoconus. Journal of Cataract and Refractive Surgery 2009;35:606-7
  11. Spoerl E, Hoyer A, Pillunat LE, et al. Corneal cross-linking and safety issues. Open Ophthalmol J 2011;5:14-6
  12. Ambach W, Blumthaler M, Schopf T, et al. Spectral trans- mission of the optical media of the human eye with re- spect to keratitis and cataract formation. Doc Ophthalmol 1994;88:165-78
  13. Bueeler M., Spoerl E.,Seiler T. UV collagen cross-linking of the cornea: safety aspects and design of a UV illumination system Proc. SPIE 6844, Ophthalmic Technologies XVIII, 68440Z February 11, 2008
  14. Dhawan S, Rao K, Natrajan S. Complications of corneal col- lagen cross-linking. J.Ophthalmol 2011;27
  15. Raiskup F, Spoerl E. Corneal cross-linking with hypo-osmolar riboflavin solution in thin keratoconic corneas. Am